| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/10/2006 | US6984380 Therapeutic treatment or preventing autoimmune diseases, diabetes; removing cells from individual, transfecting the removed cells with DNA encoding normal major histocompatibility complex, reinfusing the transfected cells into body |
| 01/10/2006 | US6984379 Gene therapy by administration of genetically engineered CD34+ cells obtained from cord blood |
| 01/10/2006 | US6984227 Multiple beam laser sculpting system and method |
| 01/10/2006 | CA2406745C A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby |
| 01/10/2006 | CA2189831C Dna-based vaccination of fish by immersion |
| 01/10/2006 | CA2158357C Purification and molecular cloning of eg iii cellulase |
| 01/10/2006 | CA2114353C Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell |
| 01/10/2006 | CA2008700C Hybrid seed production |
| 01/09/2006 | CA2474032A1 Infectious clone of human parvovirus b19 and methods |
| 01/08/2006 | CA2509766A1 Mouse trace amine associated receptors |
| 01/08/2006 | CA2509432A1 Human trace amine associated receptors |
| 01/07/2006 | CA2509632A1 Me-5, me-2, and epp2: human protein antigens reactive with autoantibodies present in the serum of woman suffering from endometriosis |
| 01/06/2006 | CA2471063A1 Novel tfiih subunit |
| 01/05/2006 | WO2006002438A2 Human monoclonal antibodies to fc gamma receptor i (cd64) |
| 01/05/2006 | WO2006002394A2 Avirulent oncolytic herpes simplex virus strains engineered to counter the innate host response |
| 01/05/2006 | WO2006002202A2 Nerve regeneration |
| 01/05/2006 | WO2006002038A2 Immunostimulatory oligonucleotide multimers |
| 01/05/2006 | WO2006001810A2 Improved inhibitor nucleic acids |
| 01/05/2006 | WO2006001514A1 Rsf1010 derivative mob-deficient plasmid containing no antibiotic resistance gene, bacterium comprising the plasmid and method for producing useful metabolites |
| 01/05/2006 | WO2006001348A1 Inhibition of infiltration, and cell killing agent |
| 01/05/2006 | WO2006001023A2 Chimeric proteins and uses thereof |
| 01/05/2006 | WO2006001011A1 Use of mycobacterial mannosylated lipoglycans peptide mimotopes for treating inflammation |
| 01/05/2006 | WO2006000719A2 COG47 PROTEIN AND S100β GENE POLYMORPHISM |
| 01/05/2006 | WO2006000343A2 Novel gene products of bacillus licheniformis which form odorous substances and improved biotechnological production methods based thereon |
| 01/05/2006 | WO2006000319A2 Method for increasing pathogen-resistance in transgenic plants by expression of peroxidase |
| 01/05/2006 | WO2006000057A1 Antisense oligonucleotides for inducing exon skipping and methods of use thereof |
| 01/05/2006 | WO2005103267A3 Agroinoculation method for virus induced gene silencing |
| 01/05/2006 | WO2005103253A8 Synthesis of long-chain polyunsaturated fatty acids by recombinant cells |
| 01/05/2006 | WO2005103237A9 Method of constructing recombinant herpes simplex virus |
| 01/05/2006 | WO2005088308A3 Fluorescent signal emitting live cell biosensor molecules and dyes for detection and quantification of protein activities |
| 01/05/2006 | WO2005085452A8 Plants having improved yield and method for making the same |
| 01/05/2006 | WO2005085442A3 COMPOUNDS FOR HYDROLYSING RIBONUCLEIC ACIDS (RNAs) |
| 01/05/2006 | WO2005081854A3 Egf receptor epitope peptides and uses thereof |
| 01/05/2006 | WO2005077126A3 Use of PPARgamma specific inhibitors as anti-cancer therapeutics |
| 01/05/2006 | WO2005072392A3 Methods for making and using molecular switches involving circular permutation |
| 01/05/2006 | WO2005062937A3 Methods and compositions for enhancing the efficacy and specificity of single and double blunt-ended sirna |
| 01/05/2006 | WO2005049799A3 Chimeric chemokine receptor polypeptides |
| 01/05/2006 | WO2005037211A3 Methods and compositions for the treatment of neurological disease |
| 01/05/2006 | WO2005017114A3 Method of increasing metabolism and stress tolerance in a plant |
| 01/05/2006 | WO2005016947A3 ANTISENSE MODULATION OF p38 MITOGEN ACTIVATED PROTEIN KINASE EXPRESSION |
| 01/05/2006 | WO2004099420A8 Minicircle vector production |
| 01/05/2006 | WO2004097020A3 Rna interference mediated inhibition of map kinase gene expression |
| 01/05/2006 | WO2004089301A3 Compositions, splice variants and methods relating to colon specific genes and proteins |
| 01/05/2006 | WO2004069148A3 Snornai-small nucleolar rna degradation by rna interference in trypanosomatids |
| 01/05/2006 | WO2004053073A3 HIGH EFFICACY ANTISENSE Riα PKA POLY-DNP OLIGORIBONUCLEOTIDES |
| 01/05/2006 | WO2003087338A3 Her-2 receptor tyrosine kinase molecules and uses thereof |
| 01/05/2006 | WO2003031598A3 Nucleic acid and amino acid sequences encoding high-level expressor factor viii polypeptides and methods of use |
| 01/05/2006 | WO2003016493A3 Transporters and ion channels |
| 01/05/2006 | US20060005287 Wheat variety XW03R |
| 01/05/2006 | US20060005286 Production of enzymes in seeds and their use |
| 01/05/2006 | US20060005281 Production of plants having improved rooting efficiency and vase life using stress-resistance gene |
| 01/05/2006 | US20060005280 Plant galactinol synthase homologs |
| 01/05/2006 | US20060005279 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
| 01/05/2006 | US20060005278 Ethylene insensitive plants |
| 01/05/2006 | US20060005277 cDNAs encoding polypeptides |
| 01/05/2006 | US20060005276 Transgenic soybean seeds having reduced activity of lipoxygenases |
| 01/05/2006 | US20060005275 Maize metallothionein promoter |
| 01/05/2006 | US20060005274 Maize metallothionein 2 promoter and methods of use |
| 01/05/2006 | US20060005273 Novel maize split-seed explant and methods for in vitro regeneration of maize |
| 01/05/2006 | US20060005272 Method for obtaining a plant with a lasting resistance to a pathogen |
| 01/05/2006 | US20060005271 Transgenic plants expressing L3 delta proteins are resistant to trichothecene fungal toxins |
| 01/05/2006 | US20060005270 Manipulation of the phenolic acid content and digestibility of plant cell walls by targeted expression of genes encoding cell wall degrading enzymes |
| 01/05/2006 | US20060005269 Brassica with resistance to an AHAS-inhibitor herbicide and blackleg disease |
| 01/05/2006 | US20060005268 Herbicidal compound resistant plant |
| 01/05/2006 | US20060005267 Peptide deformylase |
| 01/05/2006 | US20060005266 Maize Nucleotide sequence coding for a protein with transglutaminase activity and use thereof |
| 01/05/2006 | US20060005265 Ryegrass CBF3 gene: identification and isolation |
| 01/05/2006 | US20060003961 Negative regulation of hypoxia inducible factor 1 by OS-9 |
| 01/05/2006 | US20060003955 Immunostimulatory nucleic acid molecules |
| 01/05/2006 | US20060003954 Inhibiting the expression of a wild type COL1A1 gene to treat a lung disease relating to a collagen disorder |
| 01/05/2006 | US20060003952 Oligomeric compounds having modified phosphate groups |
| 01/05/2006 | US20060003938 Novel pyrrhocoricin-derived peptides and methods of use thereof |
| 01/05/2006 | US20060003937 Urocortin-III and uses thereof |
| 01/05/2006 | US20060003934 Polypeptide; polyethylene glycolylated polypeptide; antidiabetic agents; side effect reduction |
| 01/05/2006 | US20060003928 Use of osteoprotegerin for the treatment and/or prevention of fibrotic disease |
| 01/05/2006 | US20060003915 Means and methods for the specific modulation of target genes in the cns and the eye and methods for their identification |
| 01/05/2006 | US20060003454 Non-dividing donor cells for gene transfer |
| 01/05/2006 | US20060003453 High-efficiency AAV helper functions |
| 01/05/2006 | US20060003452 Vector packaging cell line |
| 01/05/2006 | US20060003451 Cell lines and constructs useful in production of E1-deleted adenoviruses in absence of replication competent adenovirus |
| 01/05/2006 | US20060003450 introducing a selectable marker that is under the control of a promoter of a gene that is differentially expressed in neural progenitor, culturing in vitro to induce differentiation into neural progenitor cells and selecting for the marker |
| 01/05/2006 | US20060003449 Plant artificial chromosome compositions and methods |
| 01/05/2006 | US20060003435 Production by yeasts of aspartic proteinases from plant origin with sheep's, cow's, goat's milk, etc. clotting and proteolytic activity |
| 01/05/2006 | US20060003433 Catalyzing hydrolysis of xylans in beverage, feed, food or polysaccharide to produce a smaller molecular weight xylose and xylo-oligomer; have increased activity and stability at increased pH and temperature; catalyzing hydrolysis of internal beta -1,4-xylosidic or endo- beta -1,4-glucanase linkages |
| 01/05/2006 | US20060003429 Generation of hydroquinone and derivatives; obtain quinic acid, oxidize to 3,4,5-trihydroxycyclohexanone, convert 3,4,5-trihydroxycyclohexanone to hydroquinone |
| 01/05/2006 | US20060003425 Method for zymotic production of fine chemicals (meta) containing sulphur |
| 01/05/2006 | US20060003424 Method of constructing amino acid producing bacterial strains, and method of preparing amino acids by fermentation with the constructed amino acid producing bacterial strains |
| 01/05/2006 | US20060003423 Using trangenic gramnegative bacteria exhibiting an overexpression of succinyl-CoA synthetase (SUC) as bioreactor for fermentation of threonine for use in medicine, cosmetics and animal feeds |
| 01/05/2006 | US20060003420 Monomeric and dimeric fluorescent protein variants and methods for making same |
| 01/05/2006 | US20060003419 Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use |
| 01/05/2006 | US20060003418 Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use |
| 01/05/2006 | US20060003417 Polypeptide; polyethylene glycolylated polypeptide; antidiabetic agents; side effect reduction |
| 01/05/2006 | US20060003416 Means and methods for producing a protein through chromatin openers that are capable of rendering chromatin more accessible to transcription factors |
| 01/05/2006 | US20060003415 Acanthamoeba as a host organism, a DNA vector contains a selection marker gene which codes for a protein which, after transformation of the host organism, allows selection of positive transformants, heterologous gene for the expression of heterologous protein; neomycin phosphotransferase gene |
| 01/05/2006 | US20060003414 Signal peptide for producing a polypeptide |
| 01/05/2006 | US20060003410 Oxidoreductase for use in identifying modulators for prevention and treatment of diabetes, obesity, dyslipidemia, coronary heart, inflammatory and cancer disorders |
| 01/05/2006 | US20060003409 Novel molecules of the card-related protein family and uses thereof |
| 01/05/2006 | US20060003408 Acid-stable alpha amylases having granular starch hydrolyzing activity and enzyme compositions |
| 01/05/2006 | US20060003405 Method of expressing recombinant protein in cho cells |
| 01/05/2006 | US20060003404 Method for specific integration of t7 rna polymerase gene in the chromosome of corynebacterial and the resultant corynebacteria-t7 promoter based shuttle vector system |